By Joe Woelfel

Stock futures were rising Tuesday as the Federal Reserve kicks off a two-day meeting at which the central bank is expected to hold steady on interest rates, and ahead of earnings reports from some of the biggest names in corporate America.

These stocks were poised to make moves Tuesday:

$Sarepta Therapeutics(SRPT)$ soared 40% after being notified by the Food and Drug Administration the company may lift its voluntary pause on shipments of its gene therapy for ambulatory patients with Duchenne muscular dystrophy. Sarepta said it imminently would resume shipping Elevidys for treatment of patients who can walk with DMD. Shipments of the medicine were paused by request of the FDA following safety concerns.

Whirlpool tumbled 15% after the appliance maker reduced its full-year adjusted earnings guidance to between $6 and $8 a share, down from previous expectations of $10, saying it believes "evolving tariff policies will ultimately support domestic manufacturers." Second-quarter earnings and revenue missed analysts' estimates as the period "continued to be impacted by competitors stockpiling Asian imports into the U.S," Whirlpool said. The company added it was recommending to its board an annual dividend of $3.60 a share, down from $7.

VeriSign fell 5.6% after the domain-name-registry provider launched a secondary offering by affiliates of Berkshire Hathaway for 4.3 million VeriSign common shares. The sale will bring Berkshire Hathaway's stake in VeriSign below 10%. Berkshire will own about 9 million shares following the deal, which will be underwritten by J.P. Morgan.

Cadence Design Systems, a maker of electronic systems and software, reported second-quarter adjusted earnings of $1.65 a share, topping analysts' consensus of $1.56, and raised expectations for fiscal-year adjusted profit to $6.85 to $6.95 a share, which also was better than current estimates. The company also said it would pay $140.6 million under a plea agreement with the U.S. government to settle claims it illegally exported products to China between 2015 and 2021. Shares rose 6.8%.

Nucor was falling 5.6% after the largest steel maker in the U.S. posted second-quarter earnings and revenue that missed analysts' estimates and said it expects third-quarter earnings "to be nominally lower than the second quarter of 2025, due to decreased earnings in the steel mills segment and similar earnings in the steel products and raw materials segments."

Exelixis declined 12% after the biotechnology company reported a drop in second-quarter earnings as revenue fell 11% to $568.3 million. Adjusted earnings in the quarter of 75 cents a share easily topped analysts' expectations of 42 cents.

Earnings reports are expected Tuesday from UnitedHealth Group, Boeing, Procter & Gamble, $United Parcel Service(UPS)$, Visa, Merck, Booking Holdings, Starbucks, Spotify Technology, Royal Caribbean, PayPal Holdings, SoFi Technologies, Electronic Arts, Carrier Global, $Norfolk Southern(NSC)$, and Electronic Arts.

UnitedHealth was up 1% in premarket trading ahead of second-quarter earnings from the healthcare company. Coming into the report, UnitedHealth has declined 44% in 2025, selling off after earnings misses, guidance cuts, Medicare Advantage blowups, and a range of other troubles. The company pulled its full-year earnings guidance in May and said it would replace CEO Andrew Witty with Chairman Stephen Hemsley, who had served as chief executive from 2006 through 2017.

Shares of Boeing were rising 0.2%. The aerospace giant is expected by analysts to report a second-quarter loss of $1.40 a share on revenue of $22.15 billion, up from $16.9 billion a year earlier. Revenue has risen along with an increase in commercial jet deliveries. Boeing is scheduled to issue its report before the trading day Tuesday.